Breast carcinoma in situ incidence rates (European age-standardised
Breast Carcinoma In Situ (D05), Number of New Cases, Crude and European Age-Standardised (AS) Incidence Rates per 100,000 Population, UK, 2017
|AS Rate - 95% LCL||25.3||15.2||23.7||24.2||24.6|
|AS Rate - 95% UCL||26.5||18.1||28.6||31.1||25.7|
|AS Rate - 95% LCL||0.1||0.0||0.0||0.0||0.1|
|AS Rate - 95% UCL||0.2||0.2||0.4||0.3||0.2|
|AS Rate - 95% LCL||13.1||7.9||12.3||12.5||12.7|
|AS Rate - 95% UCL||13.7||9.5||14.9||16.1||13.3|
For breast cancinoma in situ, like most cancer types, differences between countries largely reflect risk factor prevalence in years past.
Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, November 2019. Similar data can be found here: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/cancerregistrationstatisticsengland/previousReleases
Data were provided by ISD Scotland on request, April 2019. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications.
Data were provided by the Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales on request, December 2019. Similar data can be found here: http://www.wcisu.wales.nhs.uk.
Data were provided by the Northern Ireland Cancer Registry on request, May 2019. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.
About this data
Data is for UK, 2017, ICD-10 D05.